Pasqualini Claudia, Kozaki Tatsuya, Bruschi Marco, Nguyen Thi Hai Hoa, Minard-Colin Véronique, Castel David, Grill Jacques, Ginhoux Florent
Children and Adolescent Oncology Department, Gustave Roussy, Paris-Saclay University, Villejuif, France.
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Neuron. 2020 Dec 23;108(6):1025-1044. doi: 10.1016/j.neuron.2020.09.018. Epub 2020 Oct 15.
Despite considerable recent advances in understanding and treating many other cancers, malignant brain tumors remain associated with low survival or severe long-term sequelae. Limited progress, including development of immunotherapies, relates in part to difficulties in accurately reproducing brain microenvironment with current preclinical models. The cellular interactions among resident microglia, recruited tumor-associated macrophages, stromal cells, glial cells, neurons, and cancer cells and how they affect tumor growth or behavior are emerging, yet many questions remain. The role of the blood-brain barrier, extracellular matrix components, and heterogeneity among tumor types and within different regions of a single tumor further complicate the matter. Here, we focus on brain microenvironment features impacted by tumor biology. We also discuss limits of current preclinical models and how complementary models, such as humanized animals and organoids, will allow deeper mechanistic insights on cancer biology, allowing for more efficient testing of therapeutic strategies, including immunotherapy, for brain cancers.
尽管最近在理解和治疗许多其他癌症方面取得了相当大的进展,但恶性脑肿瘤的生存率仍然很低,或者会导致严重的长期后遗症。包括免疫疗法的发展在内,进展有限,部分原因是目前的临床前模型难以准确再现脑微环境。驻留的小胶质细胞、募集的肿瘤相关巨噬细胞、基质细胞、胶质细胞、神经元和癌细胞之间的细胞相互作用以及它们如何影响肿瘤生长或行为正在逐渐显现,但仍有许多问题存在。血脑屏障、细胞外基质成分以及肿瘤类型之间和单个肿瘤不同区域内的异质性进一步使问题复杂化。在这里,我们关注受肿瘤生物学影响的脑微环境特征。我们还将讨论当前临床前模型的局限性,以及诸如人源化动物和类器官等互补模型如何能够更深入地洞察癌症生物学机制,从而更有效地测试包括免疫疗法在内的脑癌治疗策略。